» Authors » Facundo Ballester

Facundo Ballester

Explore the profile of Facundo Ballester including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 474
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Valdes-Cortez C, Mansour I, Ayala Alvarez D, Berumen F, Cote J, Ndoutoume-Paquet G, et al.
Med Phys . 2025 Feb; PMID: 40007506
Background: Low-energy x-ray beams used in electronic brachytherapy (eBT) present significant dosimetric challenges due to their high depth-dose gradients, the dependence of detector response on materials, and the lack of...
2.
Vijande J, Carmona V, Lliso F, Ballester F, Perez-Calatayud J
J Appl Clin Med Phys . 2024 Sep; 25(12):e14509. PMID: 39238193
Background: Brachytherapy (BT) treatments involving temporary high-dose rate (HDR) sources are extensively employed in clinical practice. Ensuring the consistency of all measurement equipment at the hospital level is crucial, requiring...
3.
Fletcher E, Ballester F, Beaulieu L, Morrison H, Poher A, Rivard M, et al.
Med Phys . 2024 Jul; 51(8):5783-5784. PMID: 38958554
No abstract available.
4.
Herreros A, Perez-Calatayud J, Ballester F, Abellana R, Neves J, Melo J, et al.
J Pers Med . 2024 Mar; 14(3). PMID: 38541063
(1) Background: High dose gradients and manual steps in brachytherapy treatment procedures can lead to dose errors which make the use of in vivo dosimetry (IVD) highly recommended for verifying...
5.
Piriz G, Gonzalez-Sprinberg G, Ballester F, Vijande J
Med Phys . 2024 Mar; 51(7):5094-5098. PMID: 38507246
Background: Non-melanoma skin cancer is one of the most common types of cancer and one of the main approaches is brachytherapy. For small lesions, the treatment of this cancer with...
6.
Fletcher E, Ballester F, Beaulieu L, Morrison H, Poher A, Rivard M, et al.
Med Phys . 2023 Sep; 51(1):694-706. PMID: 37665982
Purpose: A joint Working Group of the American Association of Physicists in Medicine (AAPM), the European Society for Radiotherapy and Oncology (ESTRO), and the Australasian Brachytherapy Group (ABG) was created...
7.
Beaulieu L, Ballester F, Granero D, Carlsson Tedgren A, Haworth A, Lowenstein J, et al.
Med Phys . 2023 Jul; 50(8):e946-e960. PMID: 37427750
The introduction of model-based dose calculation algorithms (MBDCAs) in brachytherapy provides an opportunity for a more accurate dose calculation and opens the possibility for novel, innovative treatment modalities. The joint...
8.
Oliver-Canamas L, Vijande J, Candela-Juan C, Gimeno-Olmos J, Pujades-Claumarchirant M, Rovira-Escutia J, et al.
Cancers (Basel) . 2023 May; 15(9). PMID: 37173950
Objectives: The main goal of this work is to design and characterize a user-friendly methodology to perform mailed dosimetric audits in high dose rate (HDR) brachytherapy for systems using either...
9.
Oliver S, Gimenez-Alventosa V, Berumen F, Gimenez V, Beaulieu L, Ballester F, et al.
Z Med Phys . 2022 Dec; 33(4):511-528. PMID: 36509574
Purpose: The purpose of this study is to validate the PenRed Monte Carlo framework for clinical applications in brachytherapy. PenRed is a C++ version of Penelope Monte Carlo code with...
10.
Perez-Calatayud J, Ballester F, Carlsson Tedgren A, DeWerd L, Papagiannis P, Rivard M, et al.
Radiother Oncol . 2022 Sep; 176:108-117. PMID: 36167195
The vast majority of radiotherapy departments in Europe using brachytherapy (BT) perform temporary implants of high- or pulsed-dose rate (HDR-PDR) sources with photon energies higher than 50 keV. Such techniques...